2004
DOI: 10.1016/s1201-9712(04)00100-6
|View full text |Cite
|
Sign up to set email alerts
|

Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000

et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2009
2009
2009
2009

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…The increasing prevalence of doxycycline resistance in various geographic locations has limited its use as treatment for many organisms including Enterobacteriaceae, S. aureus, S. pneumoniae (including penicillin-resistant pneumococci) and Bacteroides. 136 Fortunately doxycycline remains active against a wide range of other infections where its use is now first line, for example, Coxiella burnetii, Brucella melitensis, Borrelia burgdorferi , and in penicillin-allergic patients with early syphilis.…”
Section: Efficacymentioning
confidence: 99%
“…The increasing prevalence of doxycycline resistance in various geographic locations has limited its use as treatment for many organisms including Enterobacteriaceae, S. aureus, S. pneumoniae (including penicillin-resistant pneumococci) and Bacteroides. 136 Fortunately doxycycline remains active against a wide range of other infections where its use is now first line, for example, Coxiella burnetii, Brucella melitensis, Borrelia burgdorferi , and in penicillin-allergic patients with early syphilis.…”
Section: Efficacymentioning
confidence: 99%